This study aims to understand the quality of life, treatment experiences, and healthcare costs for people receiving long-term treatment for cancer-related venous thromboembolism (VTE), which are blood clots. You would complete questionnaires about your quality of life and treatment experiences. The main goal is to measure how well people stick to their blood clot medication. This is an observational study, meaning you won't receive new treatments, but your experiences will be recorded. Up to 260 adults with confirmed blood clots will participate. The study status is currently unclear.

Study design

This is an observational study, meaning no new treatments are given. Up to 260 participants will be enrolled across multiple centers.

What's involved

You would complete questionnaires at the start of the study, and then at about 30 days, 3 months, 6 months, and 12 months. Each questionnaire takes less than 10 minutes.

Compensation

Not stated in the trial record.

Follow-up

Your participation will be over after the last questionnaires are completed at about 12 months after you enroll.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.